Roche expands, adds jobs

Share this article:

Roche is taking on 500 new employees and is expanding its production capacity. The Swiss drug maker announced Monday that it was investing a total of $800 million across four locations over the next five years.

The company said in a statement that the expansions in Penzburg, Germany; Basel, Switzerland; and Vacaville and Oceanside, CA, are part of an efforts to support demand for biologics, such as Perjeta, as well as the antibody drug conjugate Kadcyla.

This may sound familiar: AstraZeneca announced Tuesday that, it, too was diving deeper into antibody drug conjugates through an acquisition and by purchasing an equity stake in an ADC-focused company.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.